Literature DB >> 8461723

Sexually transmitted diseases and HIV-1 infection among homosexual men in England and Wales.

B G Evans1, M A Catchpole, J Heptonstall, J Y Mortimer, C A McCarrigle, A G Nicoll, P Waight, O N Gill, A V Swan.   

Abstract

OBJECTIVE: To examine surveillance data for evidence of changing sexual behaviour and continuing transmission of HIV-1 among men who have sex with men.
DESIGN: Analytic study of surveillance data on sexually transmitted diseases.
SETTING: England and Wales. MAIN OUTCOME MEASURES: Number of cases of rectal gonorrhoea and newly diagnosed HIV infection in homosexual men.
RESULTS: New cases of gonorrhoea among men attending genitourinary medicine clinics increased by 7.7% in 1989 and by 4.2% in 1990. Reports of rectal isolates of Neisseria gonorrhoeae also rose and the male to female ratio for patients with rectal gonorrhoea changed from 0.3:1 during 1988-9 to 2.6:1 in 1990-1. Although the overall number of cases of acute hepatitis B fell during 1988-91, 81 and 82 homosexual men were infected in 1990 and 1991 respectively compared with 50 and 42 in 1988 and 1989. 1526 men had HIV-1 infection diagnosed in 1991, the largest number since 1987. Twenty eight of the 97 (29%) men who seroconverted between January 1989 and December 1991 were aged less than 25. The proportion of men aged 15-19 who were found to be infected with HIV-1 at their first test increased from an average of 2.4% up to 1990 to 4.7% in the first nine months of 1991. The prevalence of HIV infection in men under 25 attending genitourinary medicine clinics in London was 17% compared with 7.8% outside London.
CONCLUSION: Unsafe sexual behaviour and HIV transmissions have increased among homosexual men after a period of decline. Recent HIV transmissions may disproportionately affect younger men.

Entities:  

Mesh:

Year:  1993        PMID: 8461723      PMCID: PMC1676508          DOI: 10.1136/bmj.306.6875.426

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  13 in total

1.  Changes in sexual behaviour in a large cohort of homosexual men in England and Wales, 1988-9.

Authors:  A J Hunt; P M Davies; P Weatherburn; A P Coxon; T J McManus
Journal:  BMJ       Date:  1991-03-02

2.  Screening for hepatitis B and vaccination of homosexual men.

Authors:  R H Loke; I M Murray-Lyon; T Balachandran; B A Evans
Journal:  BMJ       Date:  1989-01-28

3.  Rectal gonorrhoea and unsafe sex.

Authors:  H Young; A Moyes; J G McKenna; A McMillan
Journal:  Lancet       Date:  1991-04-06       Impact factor: 79.321

4.  Resurgent gonorrhoea in homosexual men.

Authors:  V C Riley
Journal:  Lancet       Date:  1991-01-19       Impact factor: 79.321

5.  Resurgent gonorrhoea in homosexual men.

Authors:  M A Waugh
Journal:  Lancet       Date:  1991-02-09       Impact factor: 79.321

6.  Evidence for recent changes in sexual behaviour in homosexual men in England and Wales.

Authors:  A M Johnson; O N Gill
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1989-09-05       Impact factor: 6.237

7.  Trends in gonorrhea in homosexually active men--King County, Washington, 1989.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1989-11-10       Impact factor: 17.586

8.  Changes in sexual behaviour and incidence of gonorrhoea.

Authors:  A G Lawrence; A E Singaratnam
Journal:  Lancet       Date:  1987-04-25       Impact factor: 79.321

9.  The San Francisco Men's Health Study: III. Reduction in human immunodeficiency virus transmission among homosexual/bisexual men, 1982-86.

Authors:  W Winkelstein; M Samuel; N S Padian; J A Wiley; W Lang; R E Anderson; J A Levy
Journal:  Am J Public Health       Date:  1987-06       Impact factor: 9.308

10.  Failure to deliver hepatitis B vaccine: confessions from a genitourinary medicine clinic.

Authors:  N Bhatti; R J Gilson; M Beecham; P Williams; M P Matthews; R S Tedder; I V Weller
Journal:  BMJ       Date:  1991-07-13
View more
  25 in total

1.  Susceptibility of gonococci isolated in London to therapeutic antibiotics: establishment of a London surveillance programme. London Gonococcal Working Group.

Authors:  C A Ison; I M Martin
Journal:  Sex Transm Infect       Date:  1999-04       Impact factor: 3.519

Review 2.  Pelvic inflammatory disease epidemiology: what do we know and what do we need to know?

Authors:  I Simms; J M Stephenson
Journal:  Sex Transm Infect       Date:  2000-04       Impact factor: 3.519

3.  Factors associated with gonorrhoea in men aware of being positive for HIV infection: case-control study.

Authors:  S T Sadiq; A J Copas; A M Johnson
Journal:  BMJ       Date:  1998-10-17

4.  Why do homosexual men continue to practise unsafe sex? A critical review of a qualitative research paper.

Authors:  K A Fenton; R Power
Journal:  Genitourin Med       Date:  1997-10

Review 5.  The role of epidemiology and surveillance systems in the control of sexually transmitted diseases.

Authors:  M A Catchpole
Journal:  Genitourin Med       Date:  1996-10

6.  Surveillance of sexual behaviour among homosexual men in a central London health authority.

Authors:  A Nardone; D E Mercey; A M Johnson
Journal:  Genitourin Med       Date:  1997-06

7.  Incidence of gonorrhoea diagnosed in GUM clinics in South Thames (west) region.

Authors:  M Hickman; A Judd; H Maguire; P Hay; A Charlett; M Catchpole; A Nayagam; A Renton
Journal:  Sex Transm Infect       Date:  1999-10       Impact factor: 3.519

8.  An outbreak of a penicillin-sensitive strain of gonorrhoea in Sydney men.

Authors:  J H Rowbottom; J W Tapsall; D C Plummer; N J Bodsworth; M A MacDonald; I W Chambers; J M Kaldor
Journal:  Genitourin Med       Date:  1994-06

9.  Gonococcal infection in Edinburgh and Newcastle: serovar prevalence in relation to clinical features and sexual orientation.

Authors:  J D Ross; A Wardropper; M Sprott; A Moyes; H Young
Journal:  Genitourin Med       Date:  1994-02

10.  A national surveillance system for newly acquired HIV infection in Australia. National HIV Surveillance Committee.

Authors:  A M McDonald; D M Gertig; N Crofts; J M Kaldor
Journal:  Am J Public Health       Date:  1994-12       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.